Critical risks of haemoadsorption for COVID-19 patients and directions for future evaluations: a nationwide propensity score matched cohort study

Abstract Haemoadsorption has been suggested as treatment adjunct for sepsis and septic shock, cardiac surgery, acute respiratory distress syndrome, and coronavirus disease 2019 (COVID-19). Randomised clinical trials did not provide conclusive evidence for benefits and even suggest risks in COVID-19...

Full description

Saved in:
Bibliographic Details
Main Authors: Jan Andreas Kloka, Thomas Jasny, Oliver Old, Elina Nürenberg-Goloub, Christina Scharf, Patrick Meybohm, Alexander Supady, Kai Zacharowski, Benjamin Friedrichson
Format: Article
Language:English
Published: Nature Portfolio 2025-08-01
Series:Scientific Reports
Subjects:
Online Access:https://doi.org/10.1038/s41598-025-13860-0
Tags: Add Tag
No Tags, Be the first to tag this record!